Hyperkalemia Risk in Chronic Kidney Disease
- 1 May 2009
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 53 (5), 749-750
- https://doi.org/10.1161/hypertensionaha.108.128017
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Mechanisms of Impaired Potassium Handling With Dual Renin-Angiotensin-Aldosterone Blockade in Chronic Kidney DiseaseHypertension, 2009
- Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled TrialAmerican Journal of Kidney Diseases, 2008
- CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004American Journal of Kidney Diseases, 2008
- Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic ReviewAmerican Journal of Kidney Diseases, 2008
- Aldosterone and progression of renal diseaseCurrent Opinion in Nephrology and Hypertension, 2008
- The incidence and implications of aldosterone breakthroughNature Clinical Practice Nephrology, 2007
- The risks and benefits of therapy with aldosterone receptor antagonist therapy.Current Drug Safety, 2007
- Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney diseaseKidney International, 2006
- ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trendsNephrology Dialysis Transplantation, 2005
- Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium HomeostasisHeart Failure Reviews, 2005